medigraphic.com

2006, Number 3

<< Back

Cir Cir 2006; 74 (3)

Bone grafts in orthopedic surgery

Zárate-Kalfópulos B, Reyes-Sánchez A

Language: Spanish
References: 40
Page: 217-222
PDF size: 57.56 Kb.


ABSTRACT

In orthopedic surgery the demand for the use of bone grafts increases daily because of the increasing quantity and complexity of surgical procedures. At present, the gold standard is the autologous bone graft but the failure rate, morbidity of the donor site and limited availability have stimulated a proliferation for finding materials that work as bone graft substitutes. In order to have good success, we must know the different properties of these choices and the environment where the graft is going to be used. As bone graft substitutes and growth factors become clinical realities, a new gold standard will be defined. Tissue engineering and gene therapy techniques have the objective to create an optimum bone graft substitute with a combination of substances with properties of osteconduction, osteogenesis and osteoinduction.


REFERENCES

  1. Vacarro AR, Patel TC, Fischgrund J, Anderson DG, Truumees E, Herkowitz HN. A pilot study evaluating the safety and efficacy of OP-1 putty (shBMxP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-1892.

  2. Khan S, Hidaka C, Sandhu HS, Girardi F, Cammisa F, Diwan AD. Gene therapy for spine fusion. Orthop Clin North Am 2000; 31:473-484.

  3. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: efficacy and indications J Am Acad Orthoped Surg1995;3:1-8.

  4. Whang PG, Wang JC. Bone graft substitutes for spinal fusion. Spine J 2003;3:155-165.

  5. Stevenson S. Biology of bone grafts. Orthop Clin North Am 1999; 30:543-552.

  6. Boden SD. The biology of posterolateral lumbar spinal fusion. Orthop Clin North Am 1998;29:603-619.

  7. Greenwald S, Boden S, Goldberg V, Khan Y, Laurencin C. Bone graft substitutes: facts, fictions and applications. J Bone Joint Surg 2001; 83:S98-103.

  8. Garza CP, Mendoza OF, Galván RM, Álvarez EL. Banco de hueso y tejidos: alta tecnología disponible para los ortopedistas mexicanos. Acta Ortoped Mex 2004;18:261-265.

  9. Safdar N, Khan F, Cammisa H Jr, Sandhu S, Ashish D, et al. The biology of bone grafting. J Am Acad Orthop Surg 2005;13:77-86

  10. Cornell CN. Osteoconductive materials as substitutes for autogenous bone grafts. Orthop Clin North Am 1999;30:591-598.

  11. Boden S. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 2002;27:26-31.

  12. Bucholz RW, Carlton A, Holmes R. Interporous hydroxyapatite as bone graft substitute in tibial plateau fractures. Clin Orthop 1989; 240:53-62.

  13. Cho DY, Lee WY, Sheu PC, Chen CC. Cage containing a biphasic calcium phosphate ceramic (Triosite) for the treatment of cervical spondylosis. Surg Neurol 2005;63:497-504.

  14. Urist MR. Bone formation by autoinduction. Science 1965;150:893-899.

  15. Ludwig SC, Boden SD. Osteoinductive bone graft substitutes for spinal fusion. Orthop Clin North Am 1999;30:635-645.

  16. Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am 1997;79:495-502.

  17. Sandhu HS et al. Bone grafting for spinal fusion. Orthop Clin North Am 1999;30:685-698.

  18. Sassard WR, Eidman DK, Gray PM. Analysis of spine fusion utilizing demineralized bone matrix. Orthop Trans 1994;18:886-887.

  19. Nade S. Armstrong L, McCartney E, Baggaley B. Osteogenesis after bone marrow transplantation: the ability of ceramic materials to sustain osteogenesis from transplanted bone marrow cells: preliminary studies. Clin Orthop 1983;181:255-263.

  20. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1998;242:1528-1534.

  21. Sonobe J, Okubo Y, Kaihara S, Miyatake S, Bessho K. Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: application of biomaterial to mask the host immune response. Hum Gene Ther 2004;15:659-668.

  22. Boden SD, Adeblick TA, Sandhu HS. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-381.

  23. Vacarro AR, Patel TC, Fischgrund J, Anderson DG, Truumees E, Herkowitz HN, et al. A pilot study evaluating the safety and efficacy of OP-1 putty (shBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-1892.

  24. Widemann B, Bamdad P, Holmer C, et al. Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats. Bone 2004;34:862-868.

  25. De Biase P, Capanna R. Clinical applications of BMPs. Injury 2005; 36:43S-46S.

  26. Cook SD, Baffes GC, Wolfe MW, et al. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 1994;301:302-312.

  27. den Boer FC, Bramer JA, Blokhuis TJ, et al. Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture. Bone 2002;31:158-164.

  28. Mizumoto Y, Moseley T, Drews M, et al. Acceleration of regenerate ossification during distraction osteogenesis with recombinant human bone morphogenetic protein-7. J Bone Joint Surg Am 2003; 85A:124-130.

  29. Boden S. Bone graft and fusion-enhancing substances: practical applications of gene therapy. In: Vaccaro, ed. Principles and Practice of Spine Surgery. 1st ed. Philadelphia: Mosby; 2003. pp. 127-139.

  30. Paley D. Young MC, Wiley AM, Fornasieer VL, Jackson RW. Percutaneous bone marrow grafting of fractures and bone defects: an experimental study in rabbits. Clin Orthop 1986;208:300-311.

  31. Conolly J, Guse R, Lippiello L, Dehne R. Development of an osteogenic bone marrow preparation. J Bone Joint Surg Am 1989;71:684-91.

  32. Muschler GF, Boehm C, Easley KA. Aspiration to obtain osteoblast progenitor cells from bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 1997;79:1699-1709.

  33. Muschler GF, Nitto H, Boehrm C, Easley KA. Age and gender related changes to cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001;19:117-125.

  34. Inoue K. Ohgushi H, Yoshikawa T, et al. The effects of aging on bone formation in porous hydroxyapatite: biochemical and histologic analysis. J Bone Miner Res 1997;12:989-994.

  35. Arpornmaeklong P, Kochel M, Depprich R, et al. Influence of platelet-rich plasma PRP on osteogenic differentiation of rat bone marrow stromal cells: an in vitro study. Int J Maxillofac Surg 2004;33:60-70.

  36. Dietmar W, Hutmacher R, García A. Scaffold-based bone engineering by using genetically modified cells. Gene 2005;347:1-10.

  37. Doblaré M, García JM, Gómez MJ. Modelling bone tissue fracture and healing. Eng Fract Mec 2004;71:1809-1840.

  38. Mayer U, Joos U, Wiesmann P. Biological and biophysical principles in extracorporal bone tissue engineering. I. Int J Maxillofac Surg 2004;33:325-332.

  39. Sun JS, Yueh-Hsiu S, Lin FH. The role of muscle-derived stem cells in bone tissue engineering. Biomaterials 2005;26:3953-3960.

  40. Orban J, Marra K, Hollinger J. Composition options for tissueengineered bone. Tissue Eng 2002;8:529-539.




2020     |     www.medigraphic.com